AMERISAFE (AMSF) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Voluntary premiums on policies written rose 12.8% year-over-year, with in-force policy count up 3.4% and renewal retention at 93.8%.
Net income for Q2 2025 increased 26.9% to $13.96 million, with diluted EPS up 28.1% to $0.73.
Gross premiums written increased 4.3% year-over-year to $79.7 million, driven by higher voluntary and residual market premiums.
Maintained strong underwriting profitability and operational discipline in a competitive workers' compensation market.
Book value per share was $13.96 at quarter-end, down 11.5% year-over-year but up 3.3% from year-end 2024.
Financial highlights
Net premiums earned grew 1.1% year-over-year to $69.4 million in Q2 2025.
Net investment income declined 10.2% year-over-year to $6.7 million due to lower investable assets.
Net realized gains on investments were $3.1 million, with net unrealized gains on equity securities at $1.8 million.
Expense ratio increased to 31.3% in Q2 2025 from 29.8% in Q2 2024.
Statutory surplus grew to $257 million from $235 million at year-end 2024.
Outlook and guidance
Full-year expense ratio expected to remain in line with historical range, with Q2 at 31.3% and year-to-date at 30.6%.
The company expects no material impact from the recently enacted One Big Beautiful Bill Act (OBBBA) tax reforms.
Ongoing capital management strategies, including share repurchases and regular dividends, reflect confidence in long-term value.
Forward-looking statements caution that actual results may differ due to market, regulatory, and operational risks.
Latest events from AMERISAFE
- Premiums and policy count rose 10.2%, but net income fell 15% as loss severity increased.AMSF
Q4 202526 Feb 2026 - Net income fell as higher loss expenses offset premium growth, but capital returns remained strong.AMSF
Q2 20242 Feb 2026 - Q3 net income rose 43.8% to $14.3M, with strong premium growth and a $3.00 dividend declared.AMSF
Q3 202418 Jan 2026 - Net income dropped 47% as investment returns fell, despite higher premiums and strong retention.AMSF
Q1 202527 Dec 2025 - Net income reached $55.4M with 20.2% ROE, premium growth, and a 5.4% dividend increase.AMSF
Q4 202423 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and director stock plan amendment.AMSF
Proxy Filing1 Dec 2025 - Q3 2025 saw 7.2% premium growth, 20.5% ROE, and special and regular dividends declared.AMSF
Q3 20253 Nov 2025